[go: up one dir, main page]

FR2768338B1 - Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique - Google Patents

Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique

Info

Publication number
FR2768338B1
FR2768338B1 FR9711545A FR9711545A FR2768338B1 FR 2768338 B1 FR2768338 B1 FR 2768338B1 FR 9711545 A FR9711545 A FR 9711545A FR 9711545 A FR9711545 A FR 9711545A FR 2768338 B1 FR2768338 B1 FR 2768338B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
compositions containing
monoamine oxidase
therapeutic application
oxidase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9711545A
Other languages
English (en)
Other versions
FR2768338A1 (fr
Inventor
Henri Depoortere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9711545A priority Critical patent/FR2768338B1/fr
Priority to PCT/FR1998/001929 priority patent/WO1999013879A1/fr
Priority to AU90819/98A priority patent/AU9081998A/en
Publication of FR2768338A1 publication Critical patent/FR2768338A1/fr
Application granted granted Critical
Publication of FR2768338B1 publication Critical patent/FR2768338B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9711545A 1997-09-17 1997-09-17 Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique Expired - Fee Related FR2768338B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9711545A FR2768338B1 (fr) 1997-09-17 1997-09-17 Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique
PCT/FR1998/001929 WO1999013879A1 (fr) 1997-09-17 1998-09-10 Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique
AU90819/98A AU9081998A (en) 1997-09-17 1998-09-10 Pharmaceutical compositions containing a monoamine oxydase inhibitor and their use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9711545A FR2768338B1 (fr) 1997-09-17 1997-09-17 Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2768338A1 FR2768338A1 (fr) 1999-03-19
FR2768338B1 true FR2768338B1 (fr) 1999-10-15

Family

ID=9511158

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9711545A Expired - Fee Related FR2768338B1 (fr) 1997-09-17 1997-09-17 Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique

Country Status (3)

Country Link
AU (1) AU9081998A (fr)
FR (1) FR2768338B1 (fr)
WO (1) WO1999013879A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012190A2 (fr) * 1996-09-11 1998-03-26 Krenitsky Pharmaceutical, Inc. Composes constituant pharmacologiquement des principes actifs et leur utilisation
FR2792529B1 (fr) * 1999-04-26 2001-09-28 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
US20040024036A1 (en) * 2000-08-01 2004-02-05 Anne Charlier Pharmaceutical composition for transdermal delivery of befloxatone
DK1256343T3 (da) 2001-05-11 2006-10-30 Juergen K Dr Beck Flibanserin til behandlingen af extrapyramidale bevægelseslidelser
WO2024259412A2 (fr) * 2023-06-16 2024-12-19 Neurawell Therapeutics Polythérapies dirigées contre la dépression et d'autres troubles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9501972A (pt) * 1995-05-09 1997-08-26 Tostes Luiz Roberto Mallat Composição farmacêutica metodo para tratamento de dependência ou abuso de álcool e método para tratamento de distúrbios psiquiátricos geneticamente relacionados ao alcoolismo

Also Published As

Publication number Publication date
FR2768338A1 (fr) 1999-03-19
AU9081998A (en) 1999-04-05
WO1999013879A1 (fr) 1999-03-25

Similar Documents

Publication Publication Date Title
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
MA26568A1 (fr) Association d'un inhibiteur d'aldose-reductase et d'un inhibiteur de glycogene-phosphorylase et composition pharmaceutique la contenant
DZ1916A1 (fr) Composés nouveaux et compostions pharmaceutiques les contenant.
DZ2461A1 (fr) Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
IL138028A0 (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical use
HUP0400694A3 (en) Small molecule inhibitors of rotamase enzyme activity and pharmaceutical compositions containing the compounds
ATE263558T1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
MA26453A1 (fr) Derives de 6-phenylpyridyl-2 amine et compositions pharmaceutiques les contenant
FI965036A7 (fi) Interleukiini-beta:aa muuttavan entsyymin inhibiittoreita sekä niitä sisältävät farmaseuttiset koostumukset
HUP9801227A3 (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use
MA23895A1 (fr) Amides therapeutiques et compositions les contenant
FI973039A7 (fi) Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
FI973279A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
ATE293970T1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
MA24193A1 (fr) Procedes pour la preparation de conjugue peg-ifn alpha physiologiquement actif, et pour la preparation de compositions pharmaceutiques le contenant et leur utilisation
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
DZ2479A1 (fr) Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
ITMI942025A0 (it) Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
MA26486A1 (fr) Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse